Afatinib 20 mg, 30mg, 40 mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20 mg, 30mg, 40 mg
Reference Brands: Gilotrif (USA), Giotrif (EU/UK)
Category: Oncology Cancer Care
Afatinib is a small-molecule tyrosine kinase inhibitor that irreversibly blocks signaling by the epidermal growth factor receptor (EGFR/ErbB) family (including EGFR, HER2, HER4). It is used primarily for adult patients with metastatic non-small-cell lung cancer (NSCLC) whose tumours harbour certain EGFR gene mutations, and also for squamous NSCLC progressing after platinum-based chemotherapy.
Afatinib — third party manufacturing & bulk supply
Afatinib 20 mg, 30mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Afatinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Afatinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Afatinib →Frequently Asked Questions
Afatinib is used for the treatment of non-small cell lung cancer (NSCLC) that has specific mutations in the epidermal growth factor receptor (EGFR) gene. It is also indicated for metastatic NSCLC and certain cases of squamous cell carcinoma of the lung. Afatinib helps block cancer cell growth by inhibiting EGFR and other related receptor tyrosine kinases.
Afatinib is made from the active ingredient afatinib dimaleate, which is an irreversible inhibitor of the ErbB family of receptors, including EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4).
The trade name of Afatinib is Gilotrif in the United States and Giotrif in the European Union and the United Kingdom.
Afatinib (Gilotrif/Giotrif) is developed and marketed by Boehringer Ingelheim Pharmaceuticals.
The generic name is Afatinib Dimaleate.
The brand names are Gilotrif and Giotrif.
Afatinib is manufactured by Boehringer Ingelheim at its facilities in Germany and the United States under strict international quality and regulatory standards.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
